TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Correlation between PAD biomarker levels and walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 30 - Second Chair Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum lumen area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: pre-dose intraocular pressure change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smell identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smell intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smell related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Male Clients Who Will Undergo Circumcision
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Median Number of Days Taken for Male Clients to Undergo Circumcision
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: FRAME-001-specific immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acceleration /Activity counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appearance of the graft on AS OCT examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adverse events related to the intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in the corneal surface at 3 months post intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein-induced hyperinsulinemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Total Score on the Expectancy Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postprandial triglycerides blood levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: compassion proficiency
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Continuous component of the photoplethysmography signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: reduced occurrence of overcorrection of serum sodium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ventilatory function change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diffusion test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Radiological findings change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capillary d-BHB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Length of the second stage of labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Ventilation's efficiency/tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to definitive diagnostics or treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in Vital Capacity (VC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Variations in Postural Drop (PD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Maximal Inspiratory Pressure (MIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Patient-rated tennis elbow evaluation questionnaire (PRTEE) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-reported pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived exertion ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin aging changes evaluated by dermoscopy photoaging scale (DPAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin aging changes evaluated by Janus-3Ⓡ skin analyzer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin capacitance evaluated by the CorneometerⓇ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Transepidermal water loss evaluated by the TewameterⓇ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of grade >2 RD
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic accuracy of 68Ga citrate PET/CT scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Defibrillator efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of Internet Addiction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Systemic metabolomic and proteomic profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Unique App Sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Minutes of App Usage Per Session
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to the diabetic foot care behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge on foot care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: General foot health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WOMAC-A Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: WOMAC-C Subscale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in WOMAC pain and function subscales combined score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Yo-Yo Intermittent Recovery Test level 1 (YYIRTL-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeated sprint ability (RSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of direction test (T-drill)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment failure rate of irradiated lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance metrics for navigation-assisted chest wall resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Completion rates of outcome measures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intervention drop-out rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in PTX3 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of the Omnipod Dash insulin administration system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Problems encountered with the Omnipod Dash insulin administration system
Endpoint domain: Adverse events/effects
Primary endpoint: Change in corneometry reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Worst Average Daily Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in physical well-being
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical 5 year outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiome patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Risk Prediction of Endometrial Cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistence of Mutations and Microbiome Alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of CIN2+ diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Accuracy of CIN3+ diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Multidimensional quality of life scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Caregiver burden scale
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: sensitivity, specificity and accuracy of tissue traceability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of Subjects with a Successful Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of endometritis, wound infection, or other infection
Endpoint domain: Adverse events/effects
Primary endpoint: Changes of work productivity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in EASE score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Length of Hospital Admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improvement in Mouth Opening (Trismus)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation in social life
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change of intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Incidence of Treatment Emerging Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Phase 2 Dose (RP2D) of BMF-500
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from baseline in scores on the Credibility and Expectancy Questionnaire (CEQ) scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of COC (cumulus-oocyte complexes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in H/M ratio after a 20-minute walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medical Student Well-Being Index (MSWBI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Negative Symptoms (Self-report)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional impairment (Self-report)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Health and disability (Self-report)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: family conflict
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Preferred healthcare professional for advance care planning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in serum neutralizing antibody titers against vaccine-encoded SARS-CoV-2 S protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in suicide ideation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area Under the Plasma Concentration Curve (AUC) of Dexamethasone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) for plasma following a single dose of AR882
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) following a single dose of AR882
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to maximum plasma concentration (Tmax) following a single dose of AR882
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Recovery of Radioactivity in Urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total Recovery of Radioactivity in Feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total Recovery of Radioactivity in Total Excretion (Urine + Feces)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bacterial composition and taxonomy changes in the fecal microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urolithin levels in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Association of urolithin levels with presence (and type) of colonic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Composite event of deterioration of early motor function, severe disturbance of consciousness or death from any cause
Endpoint domain: Mortality/survival
Primary endpoint: Pain Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants Who Experienced Grades 1-5 Serious and/or Non-serious Toxicity Related to LMB-100
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Experienced Grades 1-5 Serious and/or Non-serious Toxicity Related to Ipilimumab
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of grade 3 and higher-grade treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: decrease in days and amount of illicit drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in rearrest rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Family Healthy Lifestyle Subscale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: implant positional accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular surface disease Index (OSDI) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Resident Level of Eating Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resident Intake Success Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Staff Participants Who Viewed the Intervention as Appropriate and Acceptable for Mealtime Care Practice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Concentration-Time Curve (AUC[0-inf]) of LOXO-783
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in kidney function as measured by eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in kidney function as measured by albuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in blood insulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Urinary Tract infections
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Clinician Administered PTSD Scale (CAPS) score from baseline to post-treatment assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sustained Attention to Response Task (SART) scores from baseline to post-treatment assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: immediate facial satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intracellular PO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Aortic Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in Brachial Artery Vascular Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in Sympathetic Nervous System Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: administration time frame
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Craving of ultra-processed (UP) foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Reported Low UP food intake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concentration of serum pentraxin-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High sensitive CRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic aneurysm related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Visual Analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the mHealth app intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of all-cause adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of analgesia consumption postoperative
Endpoint domain: Adverse events/effects
Primary endpoint: Metabolic processes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in urine mercury levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Bronchitis Severity Score (BSS) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Motor function recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with any AEs of severity grade 3 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Number of 8 mg aflibercept injections successfully administered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Titers of circulating anti SARS-CoV-2 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in focus
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of independent patients
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ultrasound markers of congestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: score of acute lung injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Binge Eating episodes per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory quotient during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to step out from sharpened Romberg test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hyperkalemia clinical burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Buccal volume variation (BVvT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total volume variation (TVvT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Western Ontario Rotator Cuff Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constant-Murley score (CMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American Shoulder and Elbow Surgeons Shoulder Score (ASES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fat mass from baseline after 42 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in lean mass from baseline after 42 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in peak muscular strength from baseline after 42 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: changes in lung compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MT Retention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: MT Persistence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Presence of clonal hematopoiesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adverse events recorded during and after BSG005 infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Walter Reed Visual Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Coopersmith Self-Esteem Inventory (CSEI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scoliosis Research Society-22 Quality of Life Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in brain receptor occupancy (RO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Attainment of Target Trough Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-hospitalization at 90 days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Follow-up at 12 months post-op
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Form-36 (SF-36) physical component score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EEG outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: clinic outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COPD Assessment Test (CAT) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life